Connection
Rachel Rabinovitch to Biomarkers, Tumor
This is a "connection" page, showing publications Rachel Rabinovitch has written about Biomarkers, Tumor.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.156 |
|
|
|
-
Vicini F, Shah C, Mittal K, Abraham J, Kruse M, Weinmann S, Leo M, Rabinovitch R, Wärnberg F, Whitworth PW, Czerniecki BJ, Shivers SC, Bremer T. A 7-Gene Biosignature for Ductal Carcinoma in situ of the Breast Identifies Subpopulations of HER2-positive Patients With Distinct Recurrence Rates After Breast-Conserving Surgery and Radiation Therapy. Clin Breast Cancer. 2025 Feb; 25(2):e152-e158.e1.
Score: 0.136
-
Jasem J, Fisher CM, Amini A, Shagisultanova E, Rabinovitch R, Borges VF, Elias A, Kabos P. The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided? J Natl Compr Canc Netw. 2017 04; 15(4):494-503.
Score: 0.020